These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 1473526)
81. Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells. Loercher AE; Nash MA; Kavanagh JJ; Platsoucas CD; Freedman RS J Immunol; 1999 Dec; 163(11):6251-60. PubMed ID: 10570318 [TBL] [Abstract][Full Text] [Related]
82. Immuno-phenotype and proliferative response of B-cell chronic lymphocytic leukemia. Karfa S; Gopal R; Nadkarni JS Med Oncol Tumor Pharmacother; 1990; 7(4):265-72. PubMed ID: 2149402 [TBL] [Abstract][Full Text] [Related]
83. Inhibition of in vitro lymphocyte function by cystic and ascitic fluids from ovarian cancer patients. Hess AD; Gall SA; Dawson JR Cancer Res; 1979 Jul; 39(7 Pt 1):2381-9. PubMed ID: 36225 [No Abstract] [Full Text] [Related]
85. [The comparison of biological characteristics between tumor-infiltrating lymphocytes and tumor-associated lymphocytes in ascites of epithelial ovarian carcinoma]. Kang S; Shen K; Lang J Zhonghua Fu Chan Ke Za Zhi; 1998 Oct; 33(10):607-10. PubMed ID: 10806687 [TBL] [Abstract][Full Text] [Related]
86. Differential expression of T-helper cytokines in the peritoneal fluid of women with normal ovarian cycle compared with women with chronic anovulation. Omu AE; Al-Azemi MK; Makhseed M; Al-Oattan F; Ismail AA; Al-Tahir S; Al-Busiri N Acta Obstet Gynecol Scand; 2003 Jul; 82(7):603-9. PubMed ID: 12790840 [TBL] [Abstract][Full Text] [Related]
87. Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patients. Wertel I; Surówka J; Polak G; Barczyński B; Bednarek W; Jakubowicz-Gil J; Bojarska-Junak A; Kotarski J Tumour Biol; 2015 Jun; 36(6):4811-7. PubMed ID: 25647263 [TBL] [Abstract][Full Text] [Related]
88. Quantitative estimation of suppressor/cytotoxic and helper T cells during acute and chronic Plasmodium berghei infection. Wangoo A; Kaur S; Ganguly NK; Bhatti G; Mahajan RC Immunol Cell Biol; 1990 Jun; 68 ( Pt 3)():187-90. PubMed ID: 2146216 [TBL] [Abstract][Full Text] [Related]
89. CA 125 in peritoneal fluid and serum from patients with benign gynecologic conditions and ovarian cancer. Hunter VJ; Weinberg JB; Haney AF; Soper JT; Lavin P; Metsch L; Knapp RC; Bast RC Gynecol Oncol; 1990 Feb; 36(2):161-5. PubMed ID: 2404835 [TBL] [Abstract][Full Text] [Related]
90. T-helper/T-regulator lymphocyte ratio as a new immunobiological index to quantify the anticancer immune status in cancer patients. Brivio F; Fumagalli L; Parolini D; Messina G; Rovelli F; Rescaldani R; Vigore L; Vezzo R; Vaghi M; Di Bella S; Lissoni P In Vivo; 2008; 22(5):647-50. PubMed ID: 18853761 [TBL] [Abstract][Full Text] [Related]
91. Flow cytometry-based analysis of tumor-leukocyte ratios in peritoneal fluid from patients with advanced gastric cancer. Takahashi K; Kurashina K; Saito S; Kanamaru R; Ohzawa H; Yamaguchi H; Miyato H; Hosoya Y; Lefor AK; Sata N; Kitayama J Cytometry B Clin Cytom; 2021 Nov; 100(6):666-675. PubMed ID: 33277773 [TBL] [Abstract][Full Text] [Related]
92. Correlations between postoperative recurrence of ovarian cancer and immune function, inflammatory factors and glucose metabolism. Wang J; Wang P; Liu X; Wang H; Wu X Minerva Endocrinol; 2020 Sep; 45(3):275-276. PubMed ID: 31797654 [No Abstract] [Full Text] [Related]
93. Loss of B1 and marginal zone B cells during ovarian cancer. Maslanka J; Torres G; Londregan J; Goldman N; Silberman D; Somerville J; Riggs JE Cell Immunol; 2024; 395-396():104788. PubMed ID: 38000306 [TBL] [Abstract][Full Text] [Related]
94. Prognostic value of CD4+ lymphocytes in pleural cavity of patients with non-small cell lung cancer. Takahashi K; Saito S; Kamamura Y; Katakawa M; Monden Y Thorax; 2001 Aug; 56(8):639-42. PubMed ID: 11462067 [TBL] [Abstract][Full Text] [Related]
95. Phenotype of lymphocyte in ovarian tumor peritoneal fluid. A preliminary study. Lacki J; Markowska J; Wiktorowicz K Eur J Gynaecol Oncol; 1992; 13(6):475-9. PubMed ID: 1473526 [TBL] [Abstract][Full Text] [Related]
96. The usefulness of CD4/CD8 ratio evaluation in monitoring of ovarian cancer patients. Markowska J; Lacki JK; Jaroszewski J; Wiktorowicz K Eur J Gynaecol Oncol; 1995; 16(1):54-8. PubMed ID: 7744118 [TBL] [Abstract][Full Text] [Related]
97. [Evaluation of the intracellular expression of interleukin 17 in patients with ovarian cancer]. Rogala E; Nowicka A; Bednarek W; Barczyński B; Wertel I; Zakrzewski M; Kotarski J Ginekol Pol; 2012 Jun; 83(6):424-8. PubMed ID: 22880461 [TBL] [Abstract][Full Text] [Related]
98. Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer. Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Smith CV; Pecorelli S; Radominska-Pandya A; Cannon MJ; Parham GP Gynecol Obstet Invest; 2001; 51(4):254-61. PubMed ID: 11408737 [TBL] [Abstract][Full Text] [Related]
99. Peritoneal immune system in patients with advance epithelial ovarian cancer. Wertel I; Nowicka A; Rogala E; Kotarski J Int Rev Immunol; 2011; 30(2-3):87-101. PubMed ID: 21557636 [TBL] [Abstract][Full Text] [Related]